This invention relates to the use of cyclic guanosine 3', 5'-monophosphate type five (cGMP PDE5) inhibitors (hereinafter PDE5 inhibitors), including in particular the compound sildenafil, for the treatment of chronic wounds of a non-diabetic origin including in particular chronic venous ulcers, chronic decubitus (pressure sores ) and arterial ulcers; and acute wounds.
申请公布号
WO0215893(A3)
申请公布日期
2003.03.13
申请号
WO2001IB01470
申请日期
2001.08.16
申请人
PFIZER LIMITED;DAVIES, MICHAEL, JOHN;HUGGINS, JONATHAN, PAUL;PARUMS, DINAH, VELTA;PFIZER INC.
